ORMP CIK: 1176309

Oramed Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.2
FY22:
−27.9
FY23:
−10.3
FY24:
−8.41
FY25:
−9.15
Change from FY21 to FY25
millions USD
FY21:
−23.8
FY22:
30.2
FY23:
−73.0
FY24:
106
FY25:
5.44
Change from FY21 to FY25
millions USD
FY21:
103
FY22:
10.8
FY23:
52.0
FY24:
−52.0
FY25:
−4.74
millions USD
FY21:
57.9
FY22:
13.0
FY23:
−31.4
FY24:
45.4
FY25:
−8.47
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.6
FY22:
−28.4
FY23:
−10.5
FY24:
−8.43
FY25:
−9.15

All amounts in millions USD Data source:SEC EDGAR